These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1719715)

  • 1. [The immunogenic and serological properties of the O-specific polysaccharide (L-hapten) in Shigella].
    Levenson VI; Belkin ZP; Egorova TP; Liubinskaia MM; Sazykina SIu
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jul; (7):25-9. PubMed ID: 1719715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [O-specific L-hapten in the composition of Shigella sonnei].
    Egorova TP; Sazykina SIu; Fedosova VG; Lebenson VI
    Zh Mikrobiol Epidemiol Immunobiol; 1989 Nov; (11):8-13. PubMed ID: 2482642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The immunogenic properties of the endotoxin protein: serum antibodies in animals and man].
    Belkin ZP; Egorova TP; Nartikova VF; Fedosova VG; Levenson VI
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jul; (7):73-6. PubMed ID: 1719717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa antigens as potential vaccines.
    Stanislavsky ES; Lam JS
    FEMS Microbiol Rev; 1997 Nov; 21(3):243-77. PubMed ID: 9451816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The protective properties of the endotoxin protein].
    Levenson VI; Belkin ZP; Egorova TP
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Aug; (8):5-9. PubMed ID: 1950285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant effect of bacterial LPS and/or alum precipitation in responses to polysaccharide and protein antigens.
    Seppälä IJ; Mäkelä O
    Immunology; 1984 Dec; 53(4):827-36. PubMed ID: 6209209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stimulation of the secretory IgA system in monkeys by parenteral immunization with a ribosomal Sonne dysentery vaccine].
    Dzhikidze EK; Stasilevich ZK; Salamatova SA
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Sep; (9):66-70. PubMed ID: 2462772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of Shigella sonnei phase I O-antigen.
    Kułakowska M; Romanowska E
    Arch Immunol Ther Exp (Warsz); 1981; 29(5):573-80. PubMed ID: 6181756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective ribosomal preparation from Shigella sonnei as a parenteral candidate vaccine.
    Levenson VI; Egorova TP; Belkin ZP; Fedosova VG; Subbotina JL; Rukhadze EZ; Dzhikidze EK; Stassilevich ZK
    Infect Immun; 1991 Oct; 59(10):3610-8. PubMed ID: 1716612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The characteristics of the O-specific humoral immune response of mice vaccinated with Salmonella choleraesuis antigens].
    Vaneeva NP; Alekseeva NIu; Torsunova GN; Bogdanova NB; Iastrebova NE; Elkina SI
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Nov; (11):56-9. PubMed ID: 1711262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polysaccharide nature of O antigen in protective ribosomal preparations from Shigella: experimental evidence and implications for the ribosomal vaccine concept.
    Levenson VI; Egorova TP
    Res Microbiol; 1990; 141(6):707-20. PubMed ID: 1704638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine.
    Oaks EV; Turbyfill KR
    Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The antigenic and immunogenic properties of the bivalent strain Shigella flexneri-Shigella sonnei 1 No. 200].
    Bondarenko VM; Nikolaeva AI; Marakusha BI; Belova TS
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):47-8. PubMed ID: 8553752
    [No Abstract]   [Full Text] [Related]  

  • 14. [Systemic immunological memory in enteral immunization with the O antigen from S. sonnei].
    Liubinskaia MM; Subbotina IuL; Chernokhvostova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Nov; (11):101-5. PubMed ID: 6084375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological properties of a ribosomal vaccine from S. sonnei obtained by polyethylene glycol fractionation].
    Levenson VI; Rukhadze EZ; Fedosova VG; Dzhikidze EK; Stasilevich ZK
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Nov; (11):77-81. PubMed ID: 6395593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Specificity of the protective action of a ribosomal Shigella vaccine and the absence of activity in the ribosomes from R mutants].
    Levenson VI; Rukhadze EZ; Belkin ZP; Essaulova ME
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Oct; (10):55-9. PubMed ID: 2464261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [An antigenic analysis and the protective properties of the R-form lipopolysaccharides of gram-negative bacteria].
    Stanislavskiĭ ES; Makarenko TA; Kholodkova EV; Lugowski C
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (4):52-6. PubMed ID: 9783402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunochemical characteristics of Shigella sonnei and serotype 6 Shigella flexneri lipopolysaccharides and enterobacterial common antigen.
    Romanowska E; Katzenellenbogen E; Lugowski C; Gamian A; Bogulska M
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):249-54. PubMed ID: 86336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides.
    Robbins JB; Chu C; Schneerson R
    Clin Infect Dis; 1992 Aug; 15(2):346-61. PubMed ID: 1381621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanism of the nonspecific protective action of Shigella antigens].
    Gorbunova ES; Elkina SI; Belina VB; Chekanova IuI; Vinogradov IV
    Zh Mikrobiol Epidemiol Immunobiol; 1988 May; (5):46-8. PubMed ID: 3046195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.